Sarepta Therapeutics
Trade Sarepta Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SRPT
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
SRPT Key Statistics
SRPT News
The Food and Drug Administration will request Sarepta Therapeutics to stop all shipments of its most lucrative drug after it disclosed last month that a second...
Sarepta Therapeutics (NASDAQ:SRPT) shares dropped to a new 52-week low on Friday, triggering a trading halt after Bloomberg News reported that the FDA is review...
Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New York, US, on Tuesday, Dec. 5, 202...
Analyst ratings
48%
of 27 ratingsMore SRPT News
Needham analyst Gil Blum downgraded Sarepta (SRPT) to Hold from Buy. Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...
Sarepta Therapeutics SRPT shares plummeted on Friday following reports of a third patient death linked to its gene therapy pipeline this year, further clouding...
The company, on an update conference call, says it didn’t disclose the limb girdle patient death on the Wednesday update call as it “wasn’t salient to our discu...
Shares of Sarepta Therapeutics SRPT plunged over 30% in Friday pre-market after a clinical trial participant died following treatment with a gene therapy, marki...
Sarepta Therapeutics, Inc. SRPT stock is trading higher on Thursday after the company issued an after-hours update on ongoing label expansion efforts for Elevid...
Sarepta Therapeutics Inc SRPT shares are soaring in Wednesday’s after-hours session after the company announced a strategic restructuring and cost-cutting measu...
